Tillmann Krahnke
- Hematology top 1%
- Genetics top 1%
- Rheumatology top 1%
- Oncology
- Endocrinology, Diabetes and Metabolism top 10%
- Co-authors
- Brian DrukerFrançois GuilhotRichard A. LarsonStephen G. O’BrienInsa GathmannYanfeng WangJörge E. CortesHagop M. Kantarjian
- Topics
- Chronic Lymphocytic Leukemia Research (12 papers)Chronic Myeloid Leukemia Treatments (12 papers)Eosinophilic Disorders and Syndromes (7 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Tillmann Krahnke
27 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Hematology 1.1k
- Genetics 925
- Rheumatology 683
- Oncology 151
- Endocrinology, Diabetes and Metabolism 142
Countries citing papers authored by Tillmann Krahnke
This map shows the geographic impact of Tillmann Krahnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tillmann Krahnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tillmann Krahnke more than expected).
Fields of papers citing papers by Tillmann Krahnke
This network shows the impact of papers produced by Tillmann Krahnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tillmann Krahnke. The network helps show where Tillmann Krahnke may publish in the future.
Co-authorship network of co-authors of Tillmann Krahnke
This figure shows the co-authorship network connecting the top 25 collaborators of Tillmann Krahnke. A scholar is included among the top collaborators of Tillmann Krahnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tillmann Krahnke. Tillmann Krahnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 16 | |
| 6 | 63 | |
| 7 | 15 | |
| 8 | 3 | |
| 9 | 3 | |
| 10 | 5 | |
| 11 | 12 | |
| 12 | 86 | |
| 13 | Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS studybreakdown → | 491 |
| 14 | 12 | |
| 15 | 160 | |
| 16 | 8 | |
| 17 | 4 | |
| 18 | 46 | |
| 19 | 13 | |
| 20 | 117 |
About Tillmann Krahnke
Tillmann Krahnke is a scholar working on Hematology, Genetics and Rheumatology, having authored 27 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Eosinophilic Disorders and Syndromes (7 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (925 citations) and Rheumatology (683 citations). Tillmann Krahnke has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Brian Druker, François Guilhot, Richard A. Larson, Stephen G. O’Brien, Insa Gathmann, Yanfeng Wang, Jörge E. Cortes, Hagop M. Kantarjian, Marc S. Rudoltz and Manisha Mone. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.